Diluted EPS came in at $-0.18, beat the $-0.52 consensus by $0.34.
Trailing eight quarters through Q4 2024
Common questions about Tenax Therapeutics's Q4 2024 earnings report.
Tenax Therapeutics (TENX) reported Q4 2024 earnings on March 25, 2025 before market open.
Tenax Therapeutics reported diluted EPS of $-0.18 for Q4 2024.
EPS beat the consensus estimate of $-0.52 by $0.34.
You can read the 10-K periodic report (0000950170-25-044398) directly on SEC EDGAR. The filing index links above go to sec.gov.